KINDER MORGAN, INC. (KMI) Costs and Expenses USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Kinder Morgan, Inc. quarterly Costs and Expenses history and growth rate from 2010 to 2024.
  • Kinder Morgan, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $2.62 B, a 2.78% decline year-over-year.
  • Kinder Morgan, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $11 B, a 24.5% decline year-over-year.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11 B $2.62 B -$75 M -2.78% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-19
Q4 2023 $11.1 B $2.94 B -$538 M -15.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q4 2023 $11.1 B $11.1 B -$4.06 B -26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $11.6 B $2.97 B -$1.28 B -30.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-23
Q2 2023 $12.9 B $2.47 B -$1.67 B -40.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $14.6 B $2.69 B -$575 M -17.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-19
Q4 2022 $15.1 B $3.48 B $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q4 2022 $15.1 B $15.1 B +$1.44 B +10.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $15.1 B $4.25 B +$1.27 B +42.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-23
Q2 2022 $13.9 B $4.15 B +$231 M +5.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 $13.6 B $3.27 B -$56 M -1.68% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-21
Q4 2021 $13.7 B $3.48 B +$1.34 B +62.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q4 2021 $13.7 B $13.7 B +$3.55 B +35% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $12.4 B $2.98 B +$880 M +41.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-21
Q2 2021 $11.5 B $3.91 B +$1.07 B +37.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-22
Q1 2021 $10.4 B $3.33 B +$262 M +8.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-22
Q4 2020 $10.1 B $2.14 B +$714 M +50.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q4 2020 $10.1 B $10.1 B +$1.8 B +21.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 $9.43 B $2.1 B -$163 M -7.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-22
Q2 2020 $9.59 B $2.84 B +$601 M +26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-23
Q1 2020 $8.99 B $3.06 B +$652 M +27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-23
Q4 2019 $8.34 B $1.42 B -$1.3 B -47.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-07
Q4 2019 $8.34 B $8.34 B -$2.01 B -19.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-07
Q3 2019 $9.64 B $2.26 B +$261 M +13% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $9.38 B $2.24 B -$915 M -29% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-27
Q1 2019 $10.3 B $2.41 B -$58 M -2.35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $10.4 B $2.72 B -$101 M -3.58% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-05
Q4 2018 $10.4 B $10.4 B +$174 M +1.71% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
Q3 2018 $10.5 B $2 B -$453 M -18.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-21
Q2 2018 $10.9 B $3.16 B +$706 M +28.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-19
Q1 2018 $10.2 B $2.47 B +$22 M +0.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-23
Q4 2017 $10.2 B $2.82 B +$335 M +13.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q4 2017 $10.2 B $10.2 B +$656 M +6.89% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $9.84 B $2.46 B +$7 M +0.29% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-19
Q2 2017 $9.83 B $2.45 B +$246 M +11.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-20
Q1 2017 $9.59 B $2.45 B +$68 M +2.86% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 $9.52 B $2.49 B -$1.39 B -35.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-08
Q4 2016 $9.52 B $9.52 B -$2.44 B -20.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
Q3 2016 $10.9 B $2.45 B -$538 M -18% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-20
Q2 2016 $11.4 B $2.2 B -$367 M -14.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-24
Q1 2016 $11.8 B $2.38 B -$140 M -5.56% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-21
Q4 2015 $12 B $3.88 B +$885 M +29.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-09
Q4 2015 $12 B $12 B +$178 M +1.51% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-09
Q3 2015 $11.1 B $2.99 B +$27 M +0.91% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-21
Q2 2015 $11 B $2.57 B -$353 M -12.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-22
Q1 2015 $11.4 B $2.52 B -$381 M -13.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-22
Q4 2014 $11.8 B $3 B +$280 M +10.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-10
Q4 2014 $11.8 B $11.8 B +$1.7 B +16.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-10
Q3 2014 $11.5 B $2.96 B +$244 M +8.99% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-23
Q2 2014 $11.3 B $2.92 B +$317 M +12.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
Q1 2014 $10.9 B $2.9 B +$857 M +41.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $10.1 B $2.72 B +$601 M +28.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-16
Q4 2013 $10.1 B $10.1 B +$2.7 B +36.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-16
Q3 2013 $9.48 B $2.72 B +$697 M +34.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $8.78 B $2.61 B +$700 M +36.7% Mar 31, 2013 Jun 30, 2013 10-Q 2013-08-05
Q1 2013 $8.08 B $2.04 B +$702 M +52.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $7.38 B $2.11 B +$618 M +41.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-23
Q4 2012 $7.38 B $7.38 B +$860 M +13.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
Q3 2012 $6.76 B $2.02 B +$277 M +15.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $6.49 B $1.91 B +$191 M +11.1% Mar 31, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $6.29 B $1.34 B -$226 M -14.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $6.52 B $1.5 B Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q4 2011 $6.52 B $6.52 B -$199 M -2.96% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $1.74 B -$166 M -8.71% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $1.72 B +$131 M +8.23% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $1.57 B Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $6.72 B $6.72 B Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $1.91 B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 $1.59 B Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.